107 related articles for article (PubMed ID: 35360070)
1. Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link.
Asghari A; Umetani M
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650428
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells.
Giurato G; Terenzi I; Chiuso F; Salvati A; Rizzo F; Tarallo R; Weisz A; Nassa G
Front Cell Dev Biol; 2023; 11():1308025. PubMed ID: 38099289
[No Abstract] [Full Text] [Related]
3. Endogenous estrogen receptor modulating oxysterols and breast cancer prognosis: Results from the MARIE patient cohort.
Decker NS; Johnson T; Behrens S; Obi N; Kaaks R; Chang-Claude J; Fortner RT
Br J Cancer; 2023 Aug; 129(3):492-502. PubMed ID: 37355720
[TBL] [Abstract][Full Text] [Related]
4. The emerging role of 27-hydroxycholesterol in cancer development and progression: An update.
Abdalkareem Jasim S; Kzar HH; Haider Hamad M; Ahmad I; Al-Gazally ME; Ziyadullaev S; Sivaraman R; Abed Jawad M; Thaeer Hammid A; Oudaha KH; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():109074. PubMed ID: 35978522
[TBL] [Abstract][Full Text] [Related]
5. Bird's eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes.
Kosaka S; Miyashita M; McNamala K; Nomura M; Shima H; Kawai M; Sato I; Harada-Shoji N; Ishida T; Choi MH; Sasano H
J Steroid Biochem Mol Biol; 2022 Jul; 221():106103. PubMed ID: 35367370
[TBL] [Abstract][Full Text] [Related]
6. Liver X Receptors (LXRs) in cancer-an Eagle's view on molecular insights and therapeutic opportunities.
Ramalingam PS; Elangovan S; Mekala JR; Arumugam S
Front Cell Dev Biol; 2024; 12():1386102. PubMed ID: 38550382
[TBL] [Abstract][Full Text] [Related]
7. Modulation of neural gene networks by estradiol in old rhesus macaque females.
Cervera-Juanes R; Zimmerman KD; Wilhelm L; Zhu D; Bodie J; Kohama SG; Urbanski HF
Geroscience; 2024 Mar; ():. PubMed ID: 38509416
[TBL] [Abstract][Full Text] [Related]
8. Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder.
Sun Z; Yang J; Zhou J; Zhou J; Feng L; Feng Y; He Y; Liu M; Li Y; Wang G; Li R
Biol Psychiatry Glob Open Sci; 2023 Oct; 3(4):663-672. PubMed ID: 37881566
[TBL] [Abstract][Full Text] [Related]
9. Preliminary Study on Expression and Function of the Chicken W Chromosome Gene
Lin X; Jin Z; Li S; Zheng M; Xing Y; Liu X; Lv M; Zhao M; Geng T; Gong D; Zhao D; Liu L
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240242
[TBL] [Abstract][Full Text] [Related]
10. The role of lipid metabolic reprogramming in tumor microenvironment.
Yang K; Wang X; Song C; He Z; Wang R; Xu Y; Jiang G; Wan Y; Mei J; Mao W
Theranostics; 2023; 13(6):1774-1808. PubMed ID: 37064872
[TBL] [Abstract][Full Text] [Related]
11. Neuromodulating roles of estrogen and phytoestrogens in cognitive therapeutics through epigenetic modifications during aging.
Singh P; Paramanik V
Front Aging Neurosci; 2022; 14():945076. PubMed ID: 35992599
[TBL] [Abstract][Full Text] [Related]
12. 27-Hydroxycholesterol, The Estrogen Receptor Modulator, Alters DNA Methylation in Breast Cancer.
Vini R; Rajavelu A; Sreeharshan S
Front Endocrinol (Lausanne); 2022; 13():783823. PubMed ID: 35360070
[TBL] [Abstract][Full Text] [Related]
13. 27-Hydroxycholesterol represses G9a expression via oestrogen receptor alpha in breast cancer.
Vini R; Lekshmi A; Ravindran S; Thulaseedharan JV; Sujathan K; Rajavelu A; Sreeja S
J Cell Mol Med; 2023 Sep; 27(18):2744-2755. PubMed ID: 37614064
[TBL] [Abstract][Full Text] [Related]
14. ERĪ± propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
15. Urolithin A: A promising selective estrogen receptor modulator and 27-hydroxycholesterol attenuator in breast cancer.
Vini R; Jaikumar VS; Remadevi V; Ravindran S; Azeez JM; Sasikumar A; Sundaram S; Sreeja S
Phytother Res; 2023 Oct; 37(10):4504-4521. PubMed ID: 37345359
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor as a drug target for the treatment of breast cancer.
Wu Y; Yu DD; Yan DL; Hu Y; Chen D; Liu Y; Zhang HD; Yu SR; Cao HX; Feng JF
Anticancer Drugs; 2016 Jun; 27(5):373-82. PubMed ID: 26872310
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
